申请人:Merck Patent GmbH
公开号:EP2626072A1
公开(公告)日:2013-08-14
The present invention relates to piperidine and piperazine derivatives according to formulae (Ia), (Ib) and (II) as autotaxin inhibitors and the use of such compounds for the treatment and/or prophylaxis of physiological and/or pathophysiological conditions, which are caused, mediated and/or propagated by increased lysophosphatic acid levels and/or the activation of autotaxin, in particular of different cancers.
本发明涉及根据式(Ia)、(Ib)和(II)作为自旋素抑制剂的哌啶和哌嗪衍生物,以及将此类化合物用于治疗和/或预防生理和/或病理生理状况,这些状况是由溶血磷脂酸水平升高和/或自旋素活化引起、介导和/或传播的,尤其是不同的癌症。